During a meeting at the White House, President Donald Trump announced a $500 million investment in AI infrastructure, according to the Economic Times. The same meeting saw Ellison tout the impact AI has had on health care. He specifically called out cancer detection, treatment and cancer vaccines.

BREAKING NEWS: Part of the new technology that President Trump wants to bring to the world with the creation of Stargate are individual, custom-designed mRNA vaccines created by AI. See? We told you to watch out. We are in the END TIMES, no “golden age” coming. pic.twitter.com/GpyZg8qL0m

— Now The End Begins (@NowTheEndBegins) January 21, 2025

Ellison claimed using AI, a messenger RNA-based vaccine could be produced robotically in just 48 hours. Moderna is using its mRNA technology to develop a cancer vaccine in partnership with Merck (MRK). Moderna is using the same platform it used to create its Covid vaccine, Spikevax.

Moderna stock jumped 7.3%, closing at 38.50. Shares are butting up against a ceiling at their 50-day moving average, according to MarketSurge.

Moderna representatives didn’t respond to a request for comment about the feasibility of Ellison’s claim.

Ellison is correct that tumors shed their DNA into the bloodstream. Blood tests like Guardant Health’s (GH) Shield can detect those fragments early in a patient’s cancer journey. Shield is approved to look for early signs of colorectal cancer.

Each tumor has its own unique signature. Bespoke cancer vaccines, like Moderna’s, train the body to look for early signs that cancer has returned following treatment. The immune system can then mount a response because, thanks to the cancer vaccine, it knows the tumor’s unique signature.

Moderna is testing its cancer vaccine in combination with Merck’s Keytruda. So far, the companies have presented test results from patients who have already been treated for melanoma and lung cancer. READ MORE